Live Terminal | Security Analysis of SCLP.L
TERMINAL beta
Version: 0.1
Timestamp: 1708841408.834055
Options
100220.KS
52.83%
1809.TW
51.88%
006220.KS
49.51%
0756.HK
49.35%
B7J.DE
48.43%
0T8B.F
-39.43%
009310.KS
-40.63%
SZGPF
-42.69%
GOLL4.SA
-52.40%
HGEN.L
-53.60%
AAPL $182.88 -0.81%
AMD $176.41 -3.00%
AMZN $174.58 0.00%
BRK-B $417.87 0.65%
GOOG $145.44 0.08%
IBM $185.76 0.84%
INTC $43.28 0.71%
JNJ $161.87 0.89%
JPM $184.12 0.57%
META $488.06 0.40%
MSFT $410.31 -0.33%
O $53.27 0.85%
TSLA $195.04 -1.20%
WMT $176.24 0.47%
QQQ $436.78 -0.2945%
TLT $93.87 1.3387%
VUSA.DE $89.31 0.4025%
VUAA.DE $88.65 0.3918%
FJPR.L $5.64 1.5565%
VWRP.L $97.83 0.1638%
VWRL.L $98.54 0.1626%
EMGU.L $3.60 -0.1111%
RDVY $52.42 0.3446%
FLOT $50.98 0.0000%
SCHZ $45.74 0.4171%
IBB $138.19 0.7436%
C020.DE $21.34 0.0000%
DFAX $24.72 0.0810%
LYP6.DE $226.20 0.4440%
MEUD.PA $226.19 0.4173%
IDWR.L $71.10 0.4521%
IQQW.DE $65.72 0.3972%
EXS1.DE $145.70 0.2477%
XESC.L $6865.00 0.1240%
DFAU $35.25 0.0852%
ACWV $104.02 0.2602%
VHYD.L $63.92 0.2746%
VGWD.DE $59.24 0.5602%
FXKZ.ME $303.00 0.0000%

Latest articles

No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.

Sentiment statistics ?
SCLP.L
μ null
null
null

Financial Histories

Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.

Overview
SCLP.L
Latest Performance
SCLP.L$11.25
$0.00 • 0.00%
SCLP.L
Price 11.25
Change Pct 0.00
Change Abs 0.00
Market Cap 104.4 million
Eps -0.01
Pe Ratio -11.25
Outstanding Shares 927.8 million
Volume 546361
Avg Volume 624498
Industry Biotechnology
Sector Name Health Care
Country Short Name GB
Announcement Earnings 2024-01-30 14:00:00+00:00
All metrics in USD or %.
Dividends

There is no dividend data to display. Refer our Dividend calendar for other accurate data.

Risk Profiles

Please sign up and become a member to view all risk profiles.

Competitors/Peer Groups
SCLP.L
Same Country:
Same Decade:
Intraday: +11.69%
Focus

The 'Focus' Area is meant to be an One-Pager about all Important Insights, Risks and Opportunities to solely analyze a single corporate.

Company descriptions
SCLP.L

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 for the treatment of non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers.